Zhejiang Jiuzhou Pharmaceutical's wholly-owned subsidiary has been recognized as a high-tech enterprise.
Jiuzhou Pharmaceutical (603456.SH) announcement, according to the national high-tech enterprise recognition management work leading group office...
Zhejiang Jiuzhou Pharmaceutical (603456.SH) announced that its wholly-owned subsidiary Ruibo (Hangzhou) Medical Technology Co., Ltd. (referred to as "Ruibo Hangzhou") has obtained the certification of a high-tech enterprise. The certificate number is GR202433008949, issued on December 6, 2024, and valid for three years.
According to national regulations, Ruibo Hangzhou will enjoy related tax preferential policies for high-tech enterprises for three years (2024-2026) after obtaining the certification, with a tax rate of 15% for corporate income tax.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
